HCPCS Level IIdrugActive
J7516
Inj, cyclosporine 250mg
BETOS: O1E
Effective: 2024-04-01
Referenced in 3 policies
Description
Injection, cyclosporine, 250 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Sandimmune
Manufacturer
Novartis Pharmaceuticals Corporation
HCPCS Dosage
250 MG
Billing Units
1.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.